menu
    • menu

    Company profile for Variant

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VARIANT initiated a collaborative network with various academic teams in the aim of developing diverse gene therapy approaches for treating CRX-associated retinopathies. The consortium is using complementary disease models to generate robust proofs-of-concept of therapeutic efficiency. VARIANT's proof-of-concept studies are particularly innovative. Our therapeutic strategies and drug administration methods make our product por...
    VARIANT initiated a collaborative network with various academic teams in the aim of developing diverse gene therapy approaches for treating CRX-associated retinopathies. The consortium is using complementary disease models to generate robust proofs-of-concept of therapeutic efficiency. VARIANT's proof-of-concept studies are particularly innovative. Our therapeutic strategies and drug administration methods make our product portfolio highly attractive to our future partners.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VariantUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    188 E Blaine St, Suite 126, Seattle, Washington, 98102, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.variant.paris/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spur Therapeutics To Present Gaucher Disease Gene Therapy Data
    Spur Therapeutics To Present Gaucher Disease Gene Therapy Data

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159368/0/en/Spur-Therapeutics-to-Present-New-Clinical-Data-on-Its-Gene-Therapy-Candidate-in-Gaucher-Disease-at-Upcoming-ESGCT-Annual-Congress.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Variant's Gene Replacement Therapy VAR002 Gets EMA Feedback
    Variant's Gene Replacement Therapy VAR002 Gets EMA Feedback

    03 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/variant-receives-positive-feedback-from-the-european-medicines-agency-ema-for-its-innovative-gene-replacement-therapy-var002-302419848.html

    PR NEWSWIRE
    03 Apr 2025
    Share Share
    Quantum-Si’s Preprint Advances in Protein Detection with ProteoVue
    Quantum-Si’s Preprint Advances in Protein Detection with ProteoVue

    20 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241220584164/en

    BUSINESSWIRE
    20 Dec 2024
    Share Share
    Zimbabwe reports first two mpox cases of unspecified variant
    Zimbabwe reports first two mpox cases of unspecified variant

    11 Oct 2024

    // REUTERS

    https://www.reuters.com/world/africa/zimbabwe-reports-first-two-mpox-cases-unspecified-variant-2024-10-13/

    REUTERS
    11 Oct 2024
    Share Share
    Dutch identify bluetongue variant in livestock, no available vaccine
    Dutch identify bluetongue variant in livestock, no available vaccine

    11 Oct 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/dutch-see-bluetongue-infections-with-type-which-no-vaccine-is-available-2024-10-11/

    REUTERS
    11 Oct 2024
    Share Share
    MiNK And Autonomous Partner On Metastatic Tumor Therapies
    MiNK And Autonomous Partner On Metastatic Tumor Therapies

    08 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/10/08/2959579/0/en/MiNK-Therapeutics-and-Autonomous-Therapeutics-Announce-Collaboration-to-Develop-Novel-Therapies-Targeting-Metastatic-Tumors.html

    GLOBENEWSWIRE
    08 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search